ESCRS - PP25.06 - Real-World Visual Outcomes Of A Novel Presbyopia-Correcting Iol With Wavefront-Shaping Technology Implanted In Patients With Previous Corneal Refractive Surgery

Real-World Visual Outcomes Of A Novel Presbyopia-Correcting Iol With Wavefront-Shaping Technology Implanted In Patients With Previous Corneal Refractive Surgery

Published 2022 - 40th Congress of the ESCRS

Reference: PP25.06 | Type: Free paper | DOI: 10.82333/bfkd-j772

Authors: Laureano Rementeria* 1 , Caridad Perez-Vives 2

1Medical director,Clinica Rementería,Madrid,Spain, 2Medical Director- IOLs,Alcon,Fort Worth,United States

Purpose

To report real-world visual outcomes in subjects bilaterally implanted with AcrySof IQ Vivity presbyopia-correcting IOLs (models DFT015 and DFTX15-Toric). Here, we report outcomes for the subgroup with previous corneal refractive surgery.

Setting

Multicenter, ambispective registry study conducted in Europe, the UK, Australia and New Zealand evaluating the performance of bilaterally implanted AcrySof IQ Vivity and AcrySof IQ Vivity Toric IOL in a real world setting through routine clinical practice

Methods

This is a sub-analysis of the second interim dataset, where 29 subjects with prior corneal refractive surgery have been implanted with DFT015 or DFTX15-Toric IOLs. After approximately 3 months follow-up per local clinical practice standards, binocular distance, intermediate (66 cm), and near (40 cm) uncorrected and corrected visual acuities (UCDVA/BCDVA, UCIVA/DCIVA and UCNVA/DCNVA), as well as satisfaction, spectacle independence and visual disturbances were evaluated.

Results

Subjects with previous myopia-correcting corneal refractive surgery (n=23) achieved binocular mean logMAR (SD) UCDVA of 0.092 (0.158), UCIVA 0.074 (0.078) and UCNVA 0.211 (0.181). Similarly, binocular mean UCDVA was 0.106 (0.140), UCIVA 0.043 (0.168) and UCNVA 0.173 (0.145) in subjects with previous hyperopia-correcting corneal refractive surgery (n=6). Most subjects (post-myopic: 91.3%, 87.0% and 91.3%, and post-hyperopic: 83.3%, 100% and 100%), reported no halos, glare or starbursts, respectively. Over 50% of subjects never or rarely needed to wear spectacles for distance or intermediate tasks, and 82.6% and 100% of those with post-myopic and post-hyperopic refractive surgery, respectively, were satisfied with their sight.

Conclusions

This real-world assessment of subjects with previous corneal refractive surgery and bilaterally implanted with DFT015/DFTX15-Toric IOL showed good distance (20/20), intermediate (20/25) and functional near visual outcomes (20/32), as well as high satisfaction and low levels of visual disturbances.